Breaking News Instant updates and real-time market news.

MRVL

Marvell

$15.94

-0.13 (-0.81%)

12:45
11/30/18
11/30
12:45
11/30/18
12:45

Marvell call volume above normal and directionally bullish

Bullish option flow detected in Marvell with 2,362 calls trading, 1.2x expected, and implied vol increasing over 1 point to 47.14%. 12/7 weekly 16.5 calls and Jan-19 16 puts are the most active options, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 0.30. Earnings are expected on December 4th.

  • 04

    Dec

MRVL Marvell
$15.94

-0.13 (-0.81%)

10/15/18
BMOC
10/15/18
UPGRADE
BMOC
Outperform
Marvell upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Ambrish Srivastava upgraded Marvell to Outperform from Market Perform and kept his $24 price target. The analyst says the risk-reward on the stock is "attractive as its valuation suggests a 7.8% free cash flow yield for 2019 vs. 7.1% for its peer group. Srivastava also believes that Marvell has "cleared the deck" on the estimates from its recent Cavium acquisition and is now set up to realize more synergies from the deal in 2020. The analyst is also positive on the management's track record of execution.
10/17/18
MKMP
10/17/18
NO CHANGE
Target $27
MKMP
Buy
Marvell management 'conservative' on various upside drivers, says MKM Partners
MKM Partners analyst Ruben Roy kept his Buy rating and $27 price target on Marvell, saying he remains positive on the company after its recent investor meeting where the management forecast annualized growth of 6%-8% for the next several years. The analyst adds that the company is likely being conservative with its guidance given the "various upside drivers" for Marvell that include AI and 5G technologies. Roy also points to Marvell's discount valuation of 13-times forward earnings relative to the 16.3-times peer group average.
10/26/18
BNCH
10/26/18
NO CHANGE
Target $100
BNCH
Buy
Mellanox a 'prized' target for 'host of buyers,' says Benchmark
After CNBC reported that Mellanox (MLNX) has hired an advisor to explore strategic alternatives, including a possible sale, Benchmark analyst Gary Mobley said it is difficult to verify the story but he believes the company would "represent a prized M&A target for a host of buyers," including potentially Nvidia (NVDA), Intel (INTC), Broadcom (AVGO), Marvell (MRVL) and "even" IBM (IBM). The analyst, who added that Mellanox's "initial apathy" toward prior M&A talks with Marvell was part of the reason Starboard got involved, keeps a Buy rating on Mellanox shares with a $100 price target.
11/29/18
MKMP
11/29/18
NO CHANGE
Target $27
MKMP
Buy
Marvell well positioned for 2019, says MKM Partners
MKM Partners analyst Ruben Roy kept his Buy rating and $27 price target on Marvell, saying that in spite of the disappointing performance of its stock price year-to-date, the stock remains one his his "top ideas". The analyst warns that the stock may be heading for more near-term headwinds given the recent NAND memory price declines with added potential for demand shifts from HDDs to SSDs. However, Roy also sees Marvell valuation reflecting those risks with the stock trading at about 10-times forward earnings relative to its peer group average of 15-times. The analyst believes that the company remains well-positioned longer term, with new market opportunities positioning it for annualized revenue growth that's in line with its target of 6%-8%.

TODAY'S FREE FLY STORIES

BCS

Barclays

$8.98

0.01 (0.11%)

13:35
12/12/19
12/12
13:35
12/12/19
13:35
Options
Barclays put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.37

0.385 (3.51%)

13:20
12/12/19
12/12
13:20
12/12/19
13:20
Options
Largest trade of the day is a Jan 2021 GE 1x3 totalling 108K contracts »

Largest trade of the day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

13:20
12/12/19
12/12
13:20
12/12/19
13:20
General news
Treasury's $16 B 30-year bond reopening was very, very well received »

Treasury's $16 B…

HIIQ

Health Insurance Innovations

$19.23

0.88 (4.80%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/12/19
12/12
13:16
12/12/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

INSG

Inseego

$7.67

0.24 (3.23%)

13:05
12/12/19
12/12
13:05
12/12/19
13:05
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.16

1.675 (48.06%)

13:00
12/12/19
12/12
13:00
12/12/19
13:00
Recommendations
Amneal Pharmaceuticals analyst commentary  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$219.47

-0.59 (-0.27%)

, PTI

Proteostasis

$4.01

-0.23 (-5.42%)

12:55
12/12/19
12/12
12:55
12/12/19
12:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

VRTX

Vertex

$219.47

-0.59 (-0.27%)

PTI

Proteostasis

$4.01

-0.23 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Mar

ADBE

Adobe

$304.30

0.55 (0.18%)

, AVGO

Broadcom

$324.00

4.14 (1.29%)

12:53
12/12/19
12/12
12:53
12/12/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$304.30

0.55 (0.18%)

AVGO

Broadcom

$324.00

4.14 (1.29%)

COST

Costco

$295.82

0.6 (0.20%)

ORCL

Oracle

$56.16

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 23

    Jan

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
U.S. Household net worth rose »

U.S. Household net worth…

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
Treasury Action: yields remain near their highs of the sessio »

Treasury Action: yields…

CC

Chemours

$17.55

0.955 (5.75%)

12:45
12/12/19
12/12
12:45
12/12/19
12:45
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:41
12/12/19
12/12
12:41
12/12/19
12:41
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

12:36
12/12/19
12/12
12:36
12/12/19
12:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

PBYI

Puma Biotechnology

$8.89

0.18 (2.07%)

12:32
12/12/19
12/12
12:32
12/12/19
12:32
Hot Stocks
Puma Biotechnology: plasmaMATCH trial shows neratinib activity in ERBB2 cancer »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

, GOOG

Alphabet

$1,346.41

1.27 (0.09%)

12:31
12/12/19
12/12
12:31
12/12/19
12:31
Hot Stocks
Google updates Messages with Verified SMS, spam protection »

Google announced in a…

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

GOOG

Alphabet

$1,346.41

1.27 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$41.93

1.7 (4.23%)

12:29
12/12/19
12/12
12:29
12/12/19
12:29
Conference/Events
GrubHub participates in a conference call with Benchmark »

Services/Media Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$30.12

-0.44 (-1.44%)

12:28
12/12/19
12/12
12:28
12/12/19
12:28
Hot Stocks
Twitter to bring back Election Labels for upcoming U.S. election »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

GOOGL

Alphabet Class A

$1,344.61

-0.04 (-0.00%)

, GOOG

Alphabet

$1,347.00

1.86 (0.14%)

12:28
12/12/19
12/12
12:28
12/12/19
12:28
On The Fly
Fly Intel: What to watch in Oracle's earnings report »

Oracle (ORCL) is…

GOOGL

Alphabet Class A

$1,344.61

-0.04 (-0.00%)

GOOG

Alphabet

$1,347.00

1.86 (0.14%)

IBM

IBM

$134.98

1.17 (0.87%)

AMZN

Amazon.com

$1,749.62

0.51 (0.03%)

MSFT

Microsoft

$151.85

0.03 (0.02%)

ORCL

Oracle

$56.15

-0.16 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BA

Boeing

$346.49

-3.51 (-1.00%)

12:26
12/12/19
12/12
12:26
12/12/19
12:26
Periodicals
Boeing CEO to meet with FAA chief Steve Dickson on Thursday, Reuters reports »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSL

Fossil

$7.72

0.36 (4.89%)

12:25
12/12/19
12/12
12:25
12/12/19
12:25
Options
Fossil Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$69.87

0.92 (1.33%)

, INTC

Intel

$57.44

0.4 (0.70%)

12:25
12/12/19
12/12
12:25
12/12/19
12:25
Conference/Events
Intel to hold a webinar »

Intel Customer Spotlight…

XOM

Exxon Mobil

$69.87

0.92 (1.33%)

INTC

Intel

$57.44

0.4 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.